Patented biomarker for cardiac injury.
A distinctive cardiac necrosis biomarker for early triaging chest pain patients. It rises faster to detectable levels compared to troponin in the event of an Acute Myocardial Infarction. This makes it suitable for PoC platforms.
Using cMyC reduces patients in observation groups in the Emergency Department => Cost saving for hospitals!
Recent publications have also shown its value in Acute Heart Failure.
A distinctive cardiac necrosis biomarker for early triaging chest pain patients. It rises faster to detectable levels compared to troponin in the event of an Acute Myocardial Infarction. This makes it suitable for PoC platforms.
Using cMyC reduces patients in observation groups in the Emergency Department => Cost saving for hospitals!
Rotating Heart Illustration 148860803 © Sutthiphorn Phanchart | Dreamstime.com
A cardiac specific biomarker for Acute Myocardial Infarction.
Rotating Heart Illustration 148860803 © Sutthiphorn Phanchart | Dreamstime.com
Imprint: KDx Acceleration, 38 rue de Berri, 75008 Paris, France
© Copyright 2021-2024 KDx Acceleration. All rights reserved.
© Copyright 2021 KDx Acceleration. All rights reserved.